CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Chronic obstructive pulmonary disease - Drugs in this topic
Scenario: Acute exacerbation
This level contains the following sections:
- AeroChamber Plus
- Airomir 100micrograms/dose Autohaler
- Airomir 100micrograms/dose inhaler
- Amoxicillin 500mg capsules
- Clarithromycin 500mg tablets
- Co-amoxiclav 500mg/125mg tablets
- Doxycycline 100mg capsules
- Erythromycin 250mg gastro-resistant tablets
- Ipratropium bromide 20micrograms/dose inhaler CFC free
- Prednisolone 5mg gastro-resistant tablets
- Prednisolone 5mg tablets
- Salamol 100micrograms/dose Easi-Breathe inhaler
- Salbutamol 100micrograms/dose inhaler CFC free
- Terbutaline 500micrograms/dose dry powder inhaler
- Tiotropium bromide 18microgram inhalation powder capsules
- Tiotropium bromide 18microgram inhalation powder capsules with device
- Tiotropium bromide 2.5micrograms/dose solution for inhalation cartridge with device CFC free
- Ventolin 100micrograms/dose Evohaler
- Volumatic
© NHS Institute for Innovation and Improvement